Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer research, Glioma, Downregulation and upregulation, microRNA, Temozolomide, and Cell cycle.
CircAFF2 Promotes Neuronal Cell Injury in Intracerebral Hemorrhage by Regulating the miR-488/CLSTN3 Axis
Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma
IRAK4 exacerbates traumatic brain injury via activation of TAK1 signaling pathway
Design of Intelligent Rehabilitation Evaluation Scale for Stroke Patients Based on Genetic Algorithm and Extreme Learning Machine
miR-720 is a key regulator of glioma migration and invasion by controlling TARSL2 expression
TGF-β1 modulates temozolomide resistance in glioblastoma via altered microRNA processing and elevated MGMT
FRK suppresses human glioma growth by inhibiting ITGB1/FAK signaling
ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1
PBX3/MEK/ERK1/2/LIN28/let-7b positive feedback loop enhances mesenchymal phenotype to promote glioblastoma migration and invasion
ERK1/2/mTOR/Stat3 pathway-mediated autophagy alleviates traumatic brain injury-induced acute lung injury
Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma
MicroRNA-1179 inhibits glioblastoma cell proliferation and cell cycle progression via directly targeting E2F transcription factor 5.
PubMed 2017cited by 48position: middle
MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.
PubMed 2017cited by 37position: first
MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.
PubMed 2017cited by 26position: middle
BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53